Abstract | OBJECTIVE: METHODS: The RA resistant APL cell lines NB4-R1 and NB4-R2 were used as in vitro models. The effect of As(2)O(3) and/or 8-CPT-cAMP was evaluated according to cellular morphology, cell surface antigen and nitroblue-tetrazolium (NBT) assay. Meanwhile, immunofluorescence analysis and Western blot assay were used to detect the degradation of PML-RAR alpha fusion protein and the change of several key cell cycle regulatory proteins in these cells before and after the treatment. RESULTS: Low dose of As(2)O(3) (0.25 micromol/L) synergized with 8-CPT-cAMP (200 micromol/L) in inducing differentiation of NB4-R1 and NB4-R2 cells, while neither of these two drugs alone could induce differentiation of these cells. In addition, 8-CPT-cAMP was able to inhibit the cell growth by modulating the expression of some important cell cycle regulators and to facilitate the As(2)O(3)-mediated degradation of PML-RAR alpha fusion protein. CONCLUSIONS:
As(2)O(3) combined with 8-CPT-cAMP could induce differentiation of RA-resistant APL cells.
|
Authors | Qi Zhu, Yun Yu, Pei-min Jia, Xun Cai, Sai-juan Chen, Zhu Chen, Zhen-yi Wang, Jian-hua Tong |
Journal | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
(Zhonghua Xue Ye Xue Za Zhi)
Vol. 24
Issue 1
Pg. 6-9
(Jan 2003)
ISSN: 0253-2727 [Print] China |
PMID | 12679001
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Arsenicals
- Oxides
- Thionucleotides
- 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP
- Tretinoin
- Cyclic AMP
- Arsenic Trioxide
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Arsenic Trioxide
- Arsenicals
(pharmacology)
- Cell Differentiation
(drug effects)
- Cell Line, Tumor
- Cyclic AMP
(analogs & derivatives, pharmacology)
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm
- Drug Synergism
- Humans
- Leukemia, Promyelocytic, Acute
(pathology)
- Oxides
(pharmacology)
- Thionucleotides
(pharmacology)
- Tretinoin
(pharmacology)
|